Navigation Links
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
Date:5/15/2008

at DDW

PEGINTRON

Results from the EPIC3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the Retreatment of Previous Interferon/Ribavirin Non-Responders (NR). Poynard, T. et al. Poster S1000, Abstract No. 442673, Sunday, May 18, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Clearance of HCV at 5 Year Follow-Up for Peginterferon Alfa-2b with or without Ribavirin Is Predicted by Sustained Virologic Response at 24 Weeks Post-Treatment. Lindsay, K. et al. Poster S1001, Abstract No. 443097, Sunday, May 18, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Sustained Virologic Response and Relapse Rates with Peginterferon Alfa-2b Plus Ribavirin in Clinical Trials Are Comparable to Those in Community-Based Studies. Manns, M. et al. Poster W1004, Abstract No. 441859, Wednesday, May 21, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Rapid Virologic Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virologic Response and Relapse. Poordad, F. et al. Poster W1007, Abstract No. 439219, Wednesday, May 21, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Boceprevir

Role of Interferon Response During Re-Treatment of Null Responders with Boceprevir Combination Therapy: Results of Phase II Trial. Schiff, E. et al. Oral Presentation 162, Abstract No. 442360, Sunday, May 18, 4:30 p.m., Room 6DE.

Schering-Plough Supported CME Symposium

Defining the Course in the Management of HCV: A Case Based Approach Sunday, May 18, 6:30-9:30 p.m., San Diego Marriott Hotel and Marina, Hall 3-6. A world-renowned faculty will present and discuss recent data and how this information may impact clinical management decisions. Among the educational objectives of this program is to define the role of viral clearance as a predictor of HCV treatment response.

About PEGINTRON

In the United States, PEGINTRON is indicated for use alone or with ribavirin for the treatment of chronic hepatitis
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
2. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
3. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
4. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
7. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
8. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
9. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... to treat voiding dysfunctions, today announced that it will ... March 10, 2015. Rob Kill , President and ... will present at 4:00 p.m. Pacific Time and meet ... the Ritz Carlton in Laguna Niguel, CA. ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the ... of its common stock at a price to the ... Tandem from this offering are expected to be $56.3 ... estimated offering expenses payable by Tandem. All of the ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... Inc. (NASDAQ: DEPO ) today announced that ... Ironwood Pharmaceuticals, Inc. following the development and delivery of ... pre-specified attributes under its Research Collaboration and License Agreement ... 2011. Under the terms of the agreement, Depomed licensed to ...
... Challenged by weak demand in its domestic markets, Allied Healthcare Products ... third quarter of fiscal year 2012 on a decline in sales. ... a negative $146,000, or negative 2 cents per basic and diluted ... for the prior year. Sales for the quarter declined from about ...
Cached Medicine Technology:Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc. 2Allied Healthcare Products Reports Loss on Sales Decline 2Allied Healthcare Products Reports Loss on Sales Decline 3Allied Healthcare Products Reports Loss on Sales Decline 4
(Date:2/28/2015)... 28, 2015 The MCA Youth Empowerment ... into one platform and gears towards the goal for ... series of group talks in smaller groups will be ... Education, Personal Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, ... of Malaysian youths. , Young adults aged ...
(Date:2/28/2015)... Heart diseases are on the rise ... urban adult population and 5 percent of rural adult ... 20-30 percent of them require specialized investigation and treatment ... vascular diseases (CVD). , A division of Indian Business ... report titled “Indian Coronary Stent Market Forecast to 2019”. ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people to ... thinking. “The #1 block was lack of time ... Haman, who created the Thinkubator Innovation Studio in Chicago. ... they did not have enough time for innovative thinking ... innovation. , Solutionman’s monthly “Accelerating Innovation Training” workshops address ...
(Date:2/28/2015)... February 28, 2015 The Heart Fit ... a distributor of the machine. The Heart Fit Clinic ... license, like a franchise model. The goal is to ... reverse heart disease. To buy External Counterpulsation ... can help individuals through this process and achieve the ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 March—also ... good time to remind ourselves and others that ... say Atlantic NeuroSurgical Specialists (ANS). , Concussions are ... account for 75% of TBIs. There are 1.6-3.8 ... may sound benign, but it is a brain ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... 5, 2011) Autism Speaks, the world,s largest autism ... leader in educating parents and professionals about the early ... University,s Autism Institute today announced the launch of a ... Video Glossary , giving parents an important new tool ...
... States, the cost paid for statins (drugs to lower ... have private insurance is approximately 400 percent higher than ... Kingdom (U.K.). These findings, from the Boston University School ... the first results of a comprehensive comparison of prescription ...
... Jan. 5 (HealthDay News) -- Man,s beloved four-legged friends not only ... understand and anticipate the intentions of their people, researchers are reporting. ... who had direct eye contact with a person were more likely ... than if the person didn,t make direct eye contact with them. ...
... More than half of U.S. jails didn,t receive any vaccine ... flu, a new study says. Jail and prison inmates ... steady stream of new arrivals can introduce new types of ... for diseases to spread, researchers from the U.S. Centers for ...
... , THURSDAY, Jan. 5 (HealthDay News) -- Giving antibiotics ... reduces infection rates in newborns, according to a new study. ... common in high-income nations and should also be used in ... study author Dr. Karen Edmond, of the London School of ...
... the Twin Cities would create both opportunities and potential risks ... would pass through, according to a health impact assessment (HIA) ... coalition of 90 congregations of various faiths in the Minneapolis, ... possible through a grant by the Health Impact Project, which ...
Cached Medicine News:Health News:Autism Speaks, FSU and First Signs launch Autism Video Glossary treatment section 2Health News:Study finds statin costs 400 percent higher in US compared to UK 2Health News:Like Babies, Dogs Pick Up on People's Intent 2Health News:Like Babies, Dogs Pick Up on People's Intent 3Health News:Many Jails Got No Flu Shots During H1N1 Outbreak: CDC 2Health News:Antibiotics in Pregnancy May Shield Newborns From Strep B 2Health News:Twin Cities light rail project presents both opportunities and risks for health, according to report 2Health News:Twin Cities light rail project presents both opportunities and risks for health, according to report 3
... is a revolutionary motorized electronic pipette. ... mind, Pipetman Concept features exclusive multifunction ... only one of its kind in ... Tips from Gilson, this product will ...
HemoNIR™ is a portable device that measures the ability of apersons blood to carry oxygen by monitoring functional vs. non functional hemoglobin....
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... The CIMScan System is ideally suited to ... are stored in hospitals and blood banks. ... to monitor various aspects of the physical ... distributed I/O components is handled over the ...
Medicine Products: